Orbimed Advisors - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 263 filers reported holding MIRATI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$89,692,218
+171.7%
2,059,050
+125.4%
1.91%
+218.7%
Q2 2023$33,010,175
-16.5%
913,650
-14.1%
0.60%
-22.9%
Q1 2023$39,546,507
-32.0%
1,063,650
-17.1%
0.78%
-30.3%
Q4 2022$58,164,085
-41.3%
1,283,692
-9.5%
1.11%
-39.5%
Q3 2022$99,095,000
+35.4%
1,418,892
+30.1%
1.84%
+38.8%
Q2 2022$73,199,000
-45.4%
1,090,400
-33.1%
1.33%
-39.0%
Q1 2022$134,060,000
-35.9%
1,630,500
+14.3%
2.17%
-19.2%
Q4 2021$209,239,000
-13.9%
1,426,400
+3.9%
2.69%
+0.7%
Q3 2021$242,933,000
+19.0%
1,373,200
+8.6%
2.67%
+29.3%
Q2 2021$204,206,000
-2.4%
1,264,200
+3.5%
2.06%
+5.6%
Q1 2021$209,192,000
-16.8%
1,221,200
+6.6%
1.96%
-11.1%
Q4 2020$251,554,000
+15.0%
1,145,300
-13.0%
2.20%
-19.9%
Q3 2020$218,688,000
+44.7%
1,317,000
-0.5%
2.75%
+29.2%
Q2 2020$151,172,000
+38.2%
1,324,100
-7.0%
2.13%
+15.7%
Q1 2020$109,409,000
-36.7%
1,423,300
+6.2%
1.84%
-25.4%
Q4 2019$172,750,000
+314.3%
1,340,600
+150.5%
2.47%
+211.8%
Q3 2019$41,693,000
+884.7%
535,143
+170.5%
0.79%
+1657.8%
Q1 2016$4,234,000
+315.9%
197,859
+514.5%
0.04%
+400.0%
Q4 2015$1,018,000
-87.7%
32,200
-86.6%
0.01%
-89.2%
Q3 2015$8,261,000
-61.4%
240,000
-64.7%
0.08%
-47.1%
Q2 2015$21,415,000
-42.4%
680,500
-46.3%
0.16%
-50.5%
Q1 2015$37,148,000
+71.9%
1,267,000
+8.6%
0.32%
+53.1%
Q4 2014$21,613,000
+5.8%
1,167,0000.0%0.21%
-2.8%
Q3 2014$20,434,000
-12.8%
1,167,000
-0.4%
0.21%
-22.5%
Q2 2014$23,440,000
-3.5%
1,172,000
-8.0%
0.28%
-8.0%
Q1 2014$24,302,000
+14.7%
1,274,3320.0%0.30%
-3.9%
Q4 2013$21,192,000
+21.7%
1,274,332
+10.9%
0.31%0.0%
Q3 2013$17,412,0001,149,3320.31%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders